These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10331823

  • 1. Itraconazole in cyclodextrin solution.
    Stevens DA.
    Pharmacotherapy; 1999 May; 19(5):603-11. PubMed ID: 10331823
    [Abstract] [Full Text] [Related]

  • 2. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T, Dressman JB, Buchanan CM, Klein S.
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [Abstract] [Full Text] [Related]

  • 3. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
    Miyake K, Irie T, Arima H, Hirayama F, Uekama K, Hirano M, Okamaoto Y.
    Int J Pharm; 1999 Mar 15; 179(2):237-45. PubMed ID: 10053216
    [Abstract] [Full Text] [Related]

  • 4. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.
    Willems L, van der Geest R, de Beule K.
    J Clin Pharm Ther; 2001 Jun 15; 26(3):159-69. PubMed ID: 11422598
    [Abstract] [Full Text] [Related]

  • 5. Displacement of itraconazole from cyclodextrin complexes in biorelevant media: In vitro evaluation of supersaturation and precipitation behavior.
    Stappaerts J, Augustijns P.
    Int J Pharm; 2016 Sep 10; 511(1):680-687. PubMed ID: 27473276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gastrointestinal behavior of itraconazole in humans - Part 1: Supersaturation from a solid dispersion and a cyclodextrin-based solution.
    Brouwers J, Geboers S, Mols R, Tack J, Augustijns P.
    Int J Pharm; 2017 Jun 15; 525(1):211-217. PubMed ID: 28414135
    [Abstract] [Full Text] [Related]

  • 9. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt.
    Kumar N, Shishu, Bansal G, Kumar S, Jana AK.
    Drug Dev Ind Pharm; 2013 Feb 15; 39(2):342-51. PubMed ID: 22553909
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7.
    Peeters J, Neeskens P, Tollenaere JP, Van Remoortere P, Brewster ME.
    J Pharm Sci; 2002 Jun 15; 91(6):1414-22. PubMed ID: 12115841
    [Abstract] [Full Text] [Related]

  • 11. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S, Elsayed I, Ismail MM.
    Int J Pharm; 2018 Oct 05; 549(1-2):249-260. PubMed ID: 30077759
    [Abstract] [Full Text] [Related]

  • 12. A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid.
    Park JW, Yun JM, Lee ES, Youn YS, Kim KS, Oh YT, Oh KT.
    Arch Pharm Res; 2013 Nov 05; 36(11):1369-76. PubMed ID: 23780798
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of itraconazole.
    De Beule K, Van Gestel J.
    Drugs; 2001 Nov 05; 61 Suppl 1():27-37. PubMed ID: 11219548
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the cyclodextrin liquid preparation of itraconazole in treatment of denture stomatitis: comparison with itraconazole capsules.
    Cross LJ, Bagg J, Aitchison TC.
    Antimicrob Agents Chemother; 2000 Feb 05; 44(2):425-7. PubMed ID: 10639376
    [Abstract] [Full Text] [Related]

  • 15. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N, Beig A, Zur M, Lindley D, Miller JM, Dahan A.
    Mol Pharm; 2017 Jun 05; 14(6):2138-2146. PubMed ID: 28505451
    [Abstract] [Full Text] [Related]

  • 16. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T, Masson M.
    Int J Pharm; 2001 Aug 28; 225(1-2):15-30. PubMed ID: 11489551
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution.
    Berben P, Mols R, Brouwers J, Tack J, Augustijns P.
    Int J Pharm; 2017 Jun 30; 526(1-2):235-243. PubMed ID: 28450167
    [Abstract] [Full Text] [Related]

  • 18. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y, Williams HD, Nguyen TH, Saunders J, Ford L, Charman SA, Scammells PJ, Porter CJ.
    Mol Pharm; 2015 Jun 01; 12(6):1980-91. PubMed ID: 25905624
    [Abstract] [Full Text] [Related]

  • 19. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
    Hong JY, Kim JK, Song YK, Park JS, Kim CK.
    J Control Release; 2006 Jan 10; 110(2):332-338. PubMed ID: 16297483
    [Abstract] [Full Text] [Related]

  • 20. A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole.
    Francois M, Snoeckx E, Putteman P, Wouters F, De Proost E, Delaet U, Peeters J, Brewster ME.
    AAPS PharmSci; 2003 Jan 10; 5(1):E5. PubMed ID: 12713277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.